ERS International Congress, Milan 2017

---

Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors

Poster Discussion
Chairs: T. Blum (Berlin, Germany), M. Evison (Manchester, United Kingdom)

LSC - 2017 - The serum levels of alpha-1 antitrypsin are strongly associated with its local production by NSCLC tumor cells A. Szpechcinski (Warszawa, Poland)
Detection of non-small cell lung cancer by an electronic nose. S. Kort (Enschede, Netherlands)
Non-invasive lung cancer diagnosis by detection of GATA6 and NKX2-1 isoforms in exhaled breath condensate G. Barreto (Bad Nauheim, Germany)
Metabolomic fingerprinting of serum samples based on direct infusion mass spectrometry for lung cancer diagnosis B. Urizar Catalan (Huelva, Spain)
Single Slide Assessment: the future of molecular testing in lung cancer? B. Diggins (Truro, United Kingdom)
Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients Y. Li (wenzhou, China)
Next generation sequencing in lung adenocarcinoma of smokers with and without chronic obstructive pulmonary disease (COPD) F. Lunardi (Padova, PD, Italy)
Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer L. Millares Costas (Badalona (Barcelona), Spain)
The significance of AEG-1 expression in NSCLL: correlation with prognostic markers. E. Chaini (Corfu, Greece)
Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer S. Yoo (Daegu, Republic of Korea)
Association of the Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 Genetic Polymorphisms with Non-small Cell Lung Cancer in Taiwan C. Shih (Taichung, Taiwan)
The value of AXL expression in squamous cell carcinoma of the lung: relationship with clinicopathological parameters. E. Chaini (Corfu, Greece)
Predictive factors and prognostic significance of T790M mutation in patients with EGFR-mutant NSCLC J. Hwang (Seoul, Republic of Korea)
T790M-mutation in EGFR progressive non-small cell lung cancer, role of re-biopsy and ctDNA analysis M. Jacob (PORTO, Portugal)
Characteristics of common and uncommon epidermal growth factor receptros gene mutations in patients with non small cell lung cancer I. Merkyte (Kaunas, Lithuania)
Survival analysis of advanced NSCLC patients harboring EGFR mutations with zoledronate or denosumab M. Miwa (Tokyo, Japan)
Comparing different initial doses of afatinib used as first-line treatment for patients with stage IV lung adenocarcinoma Y. Tsai (Kaohsiung, Taiwan)